Investigating the risks of Covid-19 vaccine supply chain

Research output: Contribution to conferencePaperpeer-review

Abstract

The development of the Covid-19 vaccines is promising to end the pandemic. However, having a safe and efficacy vaccine is one thing, ensuring them get delivered is quite another. The ‘Great Lockdown’ has not only largely restricted the movement of people and goods, but also caused significant impacts on the delivery of PPEs and other healthcare products. This study aims to understand how supply chains can mirror the demand for Covid-19 vaccinations. It employs the Protection Motiving Theory to investigate the relationships between participants’ information on vaccine availability and their decisions on vaccine uptake.
Original languageEnglish
Pages1-8
Number of pages8
Publication statusPublished - 7 Jul 2021
Event28th EurOMA Conference: Managing the “new normal”: The future of Operations and Supply Chain Management in unprecedented times - Online: University of Sussex, Brighton, United Kingdom
Duration: 5 Jul 20217 Jul 2021
https://www.euroma21.org/

Conference

Conference28th EurOMA Conference
Abbreviated titleEurOMA 2021
Country/TerritoryUnited Kingdom
CityBrighton
Period5/07/217/07/21
Internet address

Fingerprint

Dive into the research topics of 'Investigating the risks of Covid-19 vaccine supply chain'. Together they form a unique fingerprint.

Cite this